Volume Alert - INTC 33.77 Intel Corp $INTC Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - INTC 33.77 Intel Corp $INTC Hit a high today of 33.86 Closing the day 10:30 at 33.77 +0.39 +1.17% With a day low of 33.34 and a total volume of 5,652,931.

INTC Recent Posts: http://investorshangout.com/Intel-Corp-INTC-54469/

INTC Intel Corp Recent Headline News

Cash Flow Analysis on Intel Stock: 3 Things Every Shareholder Should Know
Dan Caplinger, The Motley Fool - Motley Fool - 1 hr 6 mins ago
Source: Intel. Many investors have mixed views on tech giant and Dow component Intel . On one hand, the company dominated the PC microprocessor industry for decades, helping to create the technological revolution that has changed a way of life...
QCOM: 70.72 (+0.43), INTC: 33.81 (+0.43), NVDA: 19.56 (-0.09)

Qualcomm's Apple Problem
Mark Hibben - at Seeking Alpha - 1 hr 34 mins ago

QCOM: 70.72 (+0.43), INTC: 33.81 (+0.43), AAPL: 113.28 (+2.03), NVDA: 19.56 (-0.09)

3 Best Stocks to Invest in the Internet of Things
Motley Fool Staff - Motley Fool - 2 hrs 23 mins ago
Connected devices and the Internet of Things are all the rage these days. Companies of all types  are pumping out new products and technologies at breakneck speed in hopes of cashing in on this fast-growing market. By 2019, the Internet of Things, or...
GE: 26.64 (+0.12), INTC: 33.81 (+0.43), GOOG: 547.70 (+0.39)

New Intel Report Finds 'Making' Can Engage Girls in Computer Science and Engineering, Potentially Reducing Tech Gender Gap
Business Wire - Thu Nov 13, 7:01AM CST
--NEWS HIGHLIGHTS
INTC: 33.81 (+0.43)

Amazon: ARM chipmakers are no match for Intel
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 5:36AM CST

AMZN: 315.72 (+4.21), ARMH: 41.42 (+0.03), INTC: 33.81 (+0.43)

Wall Street Breakfast: Hasbro In Talks To Buy DreamWorks Animation
Wall Street Breakfast - Seeking Alpha - Thu Nov 13, 5:30AM CST
Economy The U.S and India reached an agreement today on stockpiling of food by governments, clearing a major stumbling block for the implementation of the World Trade Organization's trade facilitation deal that has been stalled for months. The...
HURC: 39.40 (-0.03), SNE: 20.44 (-0.19), INTC: 33.81 (+0.43), GOOG: 547.70 (+0.39), NOAH: 16.92 (-0.02), SPY: 204.80 (+0.84), TRP: 50.24 (-0.12), GOOGL: 559.07 (+0.82), TWC: 140.92 (+4.44), TWTR: 42.43 (-0.11), HMC: 31.52 (+0.33), CSCO: 25.83 (+0.72), BCS: 14.45 (-0.13), HAS: 54.27 (-3.20), FB: 74.49 (-0.23), DWA: 26.30 (+3.93), MHG: 14.87 (+0.05), BA: 128.16 (+2.29), QQQ: 103.25 (+0.79), ARMH: 41.42 (+0.03), CMCSA: 54.48 (+0.88)

Intel Security and Discovery Education Launch First Digital Safety Program for Educators, Students and Parents
Business Wire - Wed Nov 12, 11:05PM CST
Intel Security, in partnership with Discovery Education, the leading provider of digital content and professional development, today announced the Intel(R) Security Digital Safety Program, a three-year national education initiative designed to teach children to "Think Before You Link" and make safer decisions when using the Internet. The first and only Discovery Education-supported initiative focusing on cybersecurity education, the Intel Security Digital Safety Program will equip educators, students and parents with the tools they need to be confident, safe digital citizens.
DISCK: 31.83 (+0.45), DISCB: 38.95 (+0.13), DISCA: 32.41 (+0.55), INTC: 33.81 (+0.43)

Most active Nasdaq-traded stocks
AP - Wed Nov 12, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 74.49 (-0.23), CMCSK: 54.28 (+0.88), ZNGA: 2.84 (+0.03), INTC: 33.81 (+0.43), GRPN: 7.92 (-0.18), SUSQ: 13.09 (-0.03), CMCSA: 54.48 (+0.88), AAPL: 113.28 (+2.03), CSCO: 25.83 (+0.72)

Intel: A Projection For 2015
Bill Maurer - at Seeking Alpha - Wed Nov 12, 12:23PM CST

INTC: 33.81 (+0.43)

The Intel Corporation Mobile Margin Myth Busted
Ashraf Eassa, The Motley Fool - Motley Fool - Wed Nov 12, 10:57AM CST
In my years following Intel , one common bearish argument that I've heard with respect to the company's mobile efforts goes a little something like this: "Intel is used to selling expensive, high-margin chips, there's no way that they...
TSM: 22.37 (+0.32), INTC: 33.82 (+0.44), AAPL: 113.29 (+2.04)

Here's How to Invest in the Internet of Things (Step 1: Keep a Level Head)
Chris Neiger, The Motley Fool - Motley Fool - Wed Nov 12, 10:00AM CST
Before investors consider jumping into an Internet of Things, or IoT, stock, it's important  to first understand exactly what IoT is, what's the real potential, and who's making some important moves in the space. The IoT isn't a get-rich-quick,...
SWIR: 38.94 (+1.64), GE: 26.64 (+0.12), CAMP: 19.23 (-0.25), QCOM: 70.72 (+0.43), INVN: 14.30 (+0.04), IT: 86.16 (+0.54), INTC: 33.82 (+0.44), CSCO: 25.83 (+0.72)

Stock Picking Grades For All Cap Growth Style Fund Managers
David Trainer - Seeking Alpha - Wed Nov 12, 8:30AM CST
This report shows how well All Cap Growth mutual fund managers pick stocks. We juxtapose our Portfolio Management Rating on funds, which grades managers based on the quality of the stocks they choose, with the number of good stocks available in the...
INTC: 33.82 (+0.44), ATHN: 124.17 (+0.99)

3 Stocks Worth Holding For The Next Decade
Leo Sun, The Motley Fool - Motley Fool - Wed Nov 12, 8:00AM CST
Tech stocks often fall into two categories -- hot growth ones and mature, income-generating ones. The former might experience extreme volatility, while the latter's price might go nowhere for years. Therefore, it can be tough to find tech stocks to...
ARMH: 41.42 (+0.03), GOOGL: 559.07 (+0.82), MSFT: 49.42 (+0.64), INTC: 33.82 (+0.44), GOOG: 547.70 (+0.39)

3 Underdog Stocks We're Watching
Motley Fool Staff - Motley Fool - Tue Nov 11, 7:03PM CST
Most investors are familiar with the adage: "Buy low, sell high." However, in reality it's often difficult to buy a beaten down stock when everyone else seems to be running for the hills. Nevertheless, this can be a very rewarding strategy for...
IBM: 162.72 (+0.80), ARMH: 41.42 (+0.03), MSFT: 49.42 (+0.64), INTC: 33.82 (+0.44)

Fossil Group Inc. Ticks Higher on Strong Earnings
Isaac Pino, CPA, The Motley Fool - Motley Fool - Tue Nov 11, 6:56PM CST
Fossil's new Retro Timer watch. Source: Fossil Shares of watchmaker Fossil gained 9% on Tuesday after the company reported sales and earnings that beat Wall Street's expectations. Coming off a rather lackluster summer, Fossil could be finding...
FOSL: 110.29 (-2.19), GOOGL: 559.14 (+0.89), KORS: 71.42 (+0.42), INTC: 33.82 (+0.44), GOOG: 547.70 (+0.39)

Where Will Intel Be in 5 Years?
Motley Fool Staff - Motley Fool - Tue Nov 11, 1:49PM CST
Intel Quark SoC. Source: Intel. Intel  has seen a lot  of change over the past 30 years, but the one near-certainty in its business since the early 1990's has been the "Wintel" duopoly the company has enjoyed with  Microsoft . However, it's not a...
AMD: 2.70 (-0.01), ARMH: 41.42 (+0.03), TSM: 22.37 (+0.32), MSFT: 49.42 (+0.64), INTC: 33.82 (+0.44), AAPL: 113.29 (+2.04), CSCO: 25.84 (+0.73)

Next Resistance Level for Intel (INTC) is $33.69
Comtex SmarTrend(R) - Tue Nov 11, 9:27AM CST
Shares of Intel (NASDAQ:INTC) opened today above their pivot of $33.28 and have already reached the first level of resistance at $33.47. Analysts will be watching for a cross of the next upside pivot targets of $33.69 and $34.10.
INTC: 33.82 (+0.44)

Intel: Memory, The Solution To The Mobile Problem
Russ Fischer - at Seeking Alpha - Tue Nov 11, 8:08AM CST

INTC: 33.82 (+0.44)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading